| 000 | 01324nam a22002417a 4500 | ||
|---|---|---|---|
| 999 |
_c8035 _d8035 |
||
| 001 | 5621 | ||
| 003 | PILC | ||
| 005 | 20240720152611.0 | ||
| 008 | 160505b2008 xxu||||| |||| 00| 0 eng d | ||
| 040 | _cFEU-NRMF MEDICAL LIBRARY | ||
| 041 | _aEnglish | ||
| 050 | _aRES OB 2008 0003 | ||
| 100 | _aSheila Magpale, M.D. | ||
| 245 | _aExtra Ovarian Primary Peritoneal Carcinoma " Ovarian Cancer in the Ovaries " | ||
| 264 | 0 | _c2008 | |
| 336 | _aText | ||
| 337 | _aUnmediated | ||
| 338 | _aVolume | ||
| 502 |
_bMEDICINE _gResearch project |
||
| 520 | _aExtraovarian Primary peritoneal Carcinoma (EOPPC), is a relatively new defined disease that develops only in women. It accounts for a total of 10% of cases with a presumed diagnosis of an Ovarian Carcinoma. Characterized by abdominal carcinomatosis, or minimally involved the ovaries, and no identifiable primary. It has been important to differentiate Extraovarian Primary Peritoneal Carcinoma to a Primary Ovarian Carcinoma although clinical manifestation and management is the same. Prognosis and survival rate in poorer in patients with Extraovarian Primary Peritoneal Carcinoma. A caseof an Extraovarian Primary Peritoneal Carcinoma it`s clinical manifestation pathogenesis and its treatment strategies is presented. | ||
| 887 | _aRES R00276 | ||
| 942 |
_2lcc _cRE |
||